Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 27, 2020
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
Wed, February 26, 2020
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
David Amsellem Initiated (AVDL) at Buy and Held Target at $14 on, Feb 26th, 2020
David Amsellem of Piper Sandler, Initiated "Avadel Pharmaceuticals plc" (AVDL) at Buy and Held Target at $14 on, Feb 26th, 2020.
David has made no other calls on AVDL in the last 4 months.
There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Francois Brisebois of "Craig-Hallum" Initiated at Strong Buy and Held Target at $15 on, Thursday, January 30th, 2020
